Reports for EMTRICITABINE

Ingredient

EMTRICITABINE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-09-04 2019-09-06 92974
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2021-04-09 2021-06-07 137241
APO-EMTRICITABINE-TENOFOVIR 200MG 300MG TABLET Resolved 2023-04-14 2023-05-19 189650
TEVA-EMTRICITABINE/TENOFOVIR 200MG 300MG TABLET Resolved 2020-11-06 2021-01-07 128004
TEVA-EMTRICITABINE/TENOFOVIR 300MG 200MG TABLET Resolved 2022-04-21 2023-06-21 159201
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Avoided shortage 2017-09-22 2018-12-19 23172
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-01-02 2019-03-29 70748
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-03 2019-04-23 80423
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-04-23 2019-06-26 82201
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 300MG 200MG TABLET Resolved 2019-07-03 2019-07-10 88291

Showing 11 to 20 of 28

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 1 of 1